Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of BLS-ILB-E710c in CIN2/3 is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia 3

Drugs mentioned

• BLS_ILB_E710c

Snippet

Sponsor: BioLeaders Corporation | Conditions: Cervical Intraepithelial Neoplasia Grade 2/3 | Phase 2 | Status: UNKNOWN